"Designing Growth Strategies is in our DNA"

U.S. Anti-obesity Drugs Market Size, Share, Analysis, By Type (Prescription Drugs and Over-the-counter (OTC) Drugs), By Distribution Channel (Hospital Pharmacy and Retail and Online Pharmacy), and Country Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI108768

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Obesity, 2023
    2. New Product Launches, By Key Players
    3. Key Industry Developments – Mergers, Acquisition, and Partnerships
    4. Pipeline Analysis, By Key Players
    5. Impact of COVID-19 on the Market
  5. U.S. Anti-obesity Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Prescription Drugs
      2. OTC Drug
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail and Online Pharmacy
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Novo Nordisk A/S
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. GSK plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. VIVUS LLC.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Currax Pharmaceuticals LLC
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. F. Hoffmann-La Roche Ltd
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Sandoz International GmbH (Novartis AG)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Boehringer Ingelheim International GmbH
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Table 01: U.S. Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 02: U.S. Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Figure 01: U.S. Anti-obesity Drugs Market Revenue Breakdown (USD billion, %), by Type, 2024 & 2032

Figure 02: U.S. Anti-obesity Drugs Market Value Share (%), by Type, 2024 & 2032

Figure 03: U.S. Anti-obesity Drugs Market Value Share (%), By Distribution Channel, 2024 & 2032

Figure 04: U.S. Anti-obesity Drugs Market Share (%), By Company, 2023

U.S. Anti-obesity Drugs Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 60
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase